SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" meme coin is gaining traction, with the community rallying behind its unique branding and "caw caw" battle cry. Active discussion revolves around its potential as a multichain gem and its strong, engaged community. Some users highlight the token's burn mechanisms.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending amidst discussions around its achieved quantum performance milestone and potential implications for the sector. The community is debating its valuation, future growth prospects, and competition within the quantum computing landscape, with some highlighting potential government contracts and partnerships while others express skepticism about commercial viability and dilution concerns.

abrdn ETF - abrdn Physical Platinum Shares ETF

PPLT is trending due to bullish sentiment and unusual options activity, with traders anticipating a potential breakout. Community members are actively discussing market manipulation, supply deficits, and platinum's historical undervaluation compared to gold. Some analysts suggest that a global hydrogen powerplant buildout will cause platinum to surge and that with the Fed cutting rates, it will explode along with gold and silver.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending after announcing positive Phase 2 trial data for its skin drug, leading to speculation about a potential buyout and future gains, though some express concern about an upcoming share offering. The community is actively discussing the drug's efficacy, comparing it to competitors, and debating its potential market value. Some traders are trying to navigate overnight trading restrictions and the possibility of shorting the stock.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

UPST is trending as investors debate its potential amid fluctuating interest rates and a high short interest. While some community members anticipate a short squeeze and highlight positive technical indicators like a doji candle, others express concern over recent price action and question its performance relative to other fintech stocks. The stock's sensitivity to rate cut news and overall market conditions is a key point of discussion.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending following the announcement of a recent private placement of approximately $44 million, sparking significant after-hours movement. The community is actively discussing the potential for continued momentum, while some are analyzing the details of the deal, particularly the warrants involved, and anticipating potential dilution. Others point to the tight float and insider holdings as a catalyst for further price action.

ETF Series Solutions Trust - Defiance Quantum ETF

QTUM is trending due to growing interest in quantum computing, with community members actively discussing the ETF's potential upside and its exposure to key players like IONQ and RGTI. Bullish sentiment is fueled by significant options activity and the expectation that government and commercial applications of quantum computing will expand. Some investors see it as a way to diversify into the quantum sector instead of choosing individual names.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as the community discusses potential partnerships with Apple and TSMC, which could significantly boost its foundry business. Bullish sentiment is fueled by government support and investment from Nvidia, although some traders are wary of the stock being overbought after a recent surge. Discussions also include potential implications of geopolitical tensions, particularly concerning Taiwan, and how that may affect Intel's position in the chip manufacturing landscape.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending as investors monitor the potential impact of fluctuating oil prices and await the company's upcoming earnings report. Community discussions also revolve around Exxon's operational strategies, including developments in Guyana and its involvement in decommissioning projects, with some speculating about potential mergers and acquisitions in the energy sector.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining ($CIFR) is trending as investors digest news of a multi-billion dollar AI compute deal potentially backstopped by Google, while also navigating a recently priced convertible bond offering. The community is actively debating the long-term implications of the deal, potential dilution, and the company's shift from Bitcoin mining to AI infrastructure. Bullish sentiment remains strong as some believe this deal validates $CIFR's position in the AI data center race.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alnylam (ALNY) Surges 6.0%: Is This an Indication of Further Gains?

Alnylam (ALNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's  What You Should Know

The mean of analysts' price targets for Foghorn Therapeutics (FHTX) points to a 130.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies IQVIA and Flagship Pioneering Announce Strategic Collaboration to...

Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?

Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Foghorn Therapeutics Inc. (FHTX) have performed compared to their sector so far this year.

Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why

Foghorn Therapeutics (FHTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing

Foghorn Therapeutics (FHTX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates

Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of +9.68% and -0.85%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of +7.69% and +3.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Foghorn Therapeutics Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

FHTX
Foghorn Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FHTX News

FHTX Foghorn Therapeutics Inc